Filing Details

Accession Number:
0001246360-13-003582
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-11 18:28:08
Reporting Period:
2013-07-10
Filing Date:
2013-07-11
Accepted Time:
2013-07-11 18:28:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64670 Medtronic Inc MDT Electromedical & Electrotherapeutic Apparatus (3845) 410793183
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379946 J Christopher Oconnell 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Evp & Grouppres Restora Therap No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-10 29,243 $46.01 146,463 No 4 M Direct
Common Stock Disposition 2013-07-10 29,243 $52.89 117,220 No 4 S Direct
Common Stock Acquisiton 2013-07-11 1,186 $46.01 118,406 No 4 M Direct
Common Stock Disposition 2013-07-11 1,186 $53.50 117,220 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-07-10 29,243 $0.00 30,429 $46.01
Common Stock Employee Stock Option (right to buy) Disposition 2013-07-11 1,186 $0.00 1,186 $46.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,186 2004-10-23 2013-10-23 No 4 M Direct
0 2004-10-23 2013-10-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,569 Indirect ESOP
Footnotes
  1. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.70 to $53.12 inclusive. The reporting person undertakes to provide to Medtronic, any security holder of Medtronic, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth.
  3. This balance increased by 1025.753 shares due to exempt transactions such as dividend reinvestment.